CSI Market
Sign In | Register

Zymeworks Inc (ZYME) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access ZYME quarterly Cash Flow →
From Zymeworks Inc through Dec 31 2021, changes in Dec 31 2025's operating cash flow provide insight into underlying business performance trends.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
12 Months 		(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Operating Activities
Income-81.13
Depreciation & amortization3.67
Amortization of Other Assets4.06
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability0.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation28.03
Income (Loss) from Equity Method Investments0.00
Foreign Currency Transaction Gain (Loss), Unrealized0.53
Accretion On Long Term Debt-
Impairment Of Intangible Assets Excluding Goodwill3.39
Increase Decrease In Amount Of Scientific Research And Experimental Development Credit Receivable-3.34
Depreciation And Amortization On Property And Equipment-
Operating Lease Right Of Use Asset Amortization-
Increase Decrease In Operating Lease Liabilities-
Licensing Agreement Noncash Consideration-
Operating Lease Right Of Use Asset Amortization Expense-
Contingent Consideration Fair Value Adjustments-
Income taxes-0.05
Unrealized Gain (Loss) on Investments0.00
Increase (Decrease) in Accounts Receivable51.20
Increase (Decrease) in Accounts Payable and Accrued Liabilities-23.65
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Prepaid Expense and Other Assets7.45
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-23.17
Discontinued operations0.00
Net Cash flow from Operating Activities-33.01
Investing Activities
Capital Expenditures-2.35
Sale of Capital Items0.00
Proceeds from Sale and Maturity of Marketable Securities225.08
Payments to Acquire Marketable Securities-196.06
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments to Acquire Long-term Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities26.66
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock-19.80
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-66.10
Payments Of Deferred Financing Fees-
Proceeds From Issuance Of Shares Under Employee Share Purchase Plan1.43
Proceeds From Issuance Of Private Placement Net Of Issuance Costs-0.18
Proceeds From Issuance Of Common Stock Public Offering-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-18.56
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-35.36
Total Cash Flow-24.95
4 historic quarters locked

Sign in to unlock the full Zymeworks Inc cash flow history.

Sign In Create Free Account

About Zymeworks Inc Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001937653-26-000015

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License